Fake drugs are one reason malaria still kills so many
Each year, 500000 people die of malaria annually, a preventable disease. Most of them children in Africa, where …
Sun Pharma recalls 200 cancer drug vials from US
Second such recall this year by pharma giant that acquired Ranbaxy earlier this year
'Indian firms most responsible in CSR'
Countries look at India as a leader to emulate, says philathropist RUTH A SHAPIRO in an interview to Down To Earth. Edited excerpts:
Average 71 patents per drug!
Innovator companies are seeking hundreds of patents on a single drug to extend monopolies and increase prices
Where are the doctors’ bodies when common man suffers due to poor treatment?
Notwithstanding lack of government support, the medical associations are strangely absent whenever the needy suffers due to unethical practices, …
85 फीसदी तक घटे कार्डिएक स्टेंट के दाम, मरीजों को राहत
ह्रदय रोगियों को बड़ी राहत देते हुए केंद्र सरकार ने कार्डिएक स्टेंट की अधिकतम कीमत निर्धारित कर दी है, जिससे इसके दाम 85 फीसदी ...
Patients pay for high margins of pharma firms
Patients in India end up paying more for medicines and all kinds of treatment as prevailing conditions do not allow the market to function …
The National Pharmaceutical Pricing Authority's efforts to reign in the private healthcare sector have been scuttled once again. Who is to be blamed?
NPPA puts price cap on cardiac stents; says hospitals overcharge
The average cost of drug eluting stent for domestic companies is around Rs 8,000 but it is sold to patients for Rs 24,000 to Rs 1.5 lakh
There's an unhealthy alliance between doctors and pharma firms
The government has shown little interest to penalise pharma companies that offer sops to doctors to push their drugs
Online drug sale ban: Is there a need to regulate e-pharmacies?
Following an interim ban on online sale of medicines, many questions have been raised on the need for checks and balances
Excessive amounts of antibiotics found in China’s rivers
Pharma companies and poultry farms behind 'illegal' discharge of antibiotics
COVID-19 exposed dependence of world, India on China for active pharma ingredients
APIs are crucial for drugs and countries have put their eggs in a single basket; India has been discussing the issue for sometime
This is how rich nations protect profits of multinational pharma firms
When rich nations insist on patent linkage provisions in bilateral and regional trade pacts, there is a way out
Trial by hire
Laissez-faire in clinical research has unleashed a ruthless profit-making machine blind to notions of justice or equity. It is time to rein in …
COVID-19 also brings focus back on pollution due to pharmaceuticals
No time for quick-fix measures. India needs stricter laws
Indian pharma firms receive 34% of FDA warnings this year
These warnings were for misbranding, selling unapproved medicines and violating Current Good Management Practices
चिकित्सकों और दवा कंपनियों की सांठगांठ
मोदी की बातों में सच्चाई है। यह बात कई बार साबित हो चुकी है कि डॉक्टर अनैतिक कार्यों में लिप्त रहे हैं। क्लिनिकल ट्रायल ...
Predatory EU pacts
EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global
COVID-19 and the big pharma mess
The pandemic has exposed a serious fault line in the global pharmaceutical supply chain, created by an industry that flourished by putting profit …
Beware of Japan's trade ambitions
Japan is pushing for higher levels of intellectual property protection that will cut access to affordable medicines
Bulk drug makers at Patancheru continue to pollute in the absence of effective vigilance, shows an analysis by the Centre for Science and Environment
Drugs pricing policy in limbo
Supreme court delays judgement on case that will help fix prices of essential medicines
Government withdraws NPPA’s power to fix prices of non-essential medicines
Prices of cardiac, diabetes, HIV/AIDS drugs likely to be affected
COVID-19 exposes India’s dependence on China for active pharma ingredients
India imports around 90 per cent of APIs used to make antibiotics, says an expert